Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wednesday, May 15, 2013 at 8:30 a.m. ET



  CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on
                   Wednesday, May 15, 2013 at 8:30 a.m. ET

PR Newswire

HAIKOU CITY, China, May 6, 2013

HAIKOU CITY, China, May 6, 2013 /PRNewswire/ -- China Pharma Holdings, Inc.
("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its 
fully-integrated specialty pharmaceuticals subsidiary based in China, today
announced that it plans to hold its first quarter of year 2013 earnings
conference call on Wednesday, May 15, 2013 at 8:30 a.m. ET.

Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for
international callers, Conference ID # 59804293. A webcast will also be
available through CPHI's website at http://www.chinapharmaholdings.com. A
replay of the call will be accessible through May 22, 2013 by dialing
1-855-452-5696 or 61-281-990-299 for international callers, Conference ID #
59804293.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical
company that develops, manufactures and markets a diversified portfolio of
products focused on conditions with a high incidence and high mortality rates
in China, including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective, high-margin business model is driven by market
demand and supported by eight scalable GMP-certified product lines covering
the major dosage forms. In addition, the Company has a broad and expanding
nationwide distribution network across all major cities and provinces in
China. The Company's wholly-owned subsidiary, Hainan Helpson Medical &
Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more
information about China Pharma Holdings, Inc., please visit
http://www.chinapharmaholdings.com. The Company routinely posts important
information on its website.

China Pharma Holdings, Inc.
86-898-66811730

SOURCE China Pharma Holdings, Inc.

Website: http://www.chinapharmaholdings.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement